MeVis Medical Solutions AG (M3V.DE)
EUR 26.2
(0.0%)
EUR 26.2
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.91 Million EUR | -36.84% |
| 2022 | 7.78 Million EUR | 71.35% |
| 2021 | 4.54 Million EUR | -20.31% |
| 2020 | 5.7 Million EUR | -29.33% |
| 2019 | 8.07 Million EUR | 12.55% |
| 2018 | 7.17 Million EUR | 27.55% |
| 2017 | 5.62 Million EUR | 23.11% |
| 2016 | 4.56 Million EUR | -32.2% |
| 2015 | 6.73 Million EUR | 81.39% |
| 2014 | 3.71 Million EUR | 0.87% |
| 2013 | 3.68 Million EUR | 70.1% |
| 2012 | 2.16 Million EUR | 152.88% |
| 2011 | -4.09 Million EUR | 50.99% |
| 2010 | -8.34 Million EUR | -2197.74% |
| 2009 | 398 Thousand EUR | -81.17% |
| 2008 | 2.11 Million EUR | 1501.52% |
| 2007 | 132 Thousand EUR | -95.5% |
| 2006 | 2.93 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.33 Million EUR | 0.0% |
| 2024 Q1 | 1.33 Million EUR | -13.89% |
| 2023 Q1 | 914.5 Thousand EUR | -58.13% |
| 2023 FY | 4.91 Million EUR | -36.84% |
| 2023 Q4 | 1.54 Million EUR | 0.0% |
| 2023 Q3 | 1.54 Million EUR | 68.97% |
| 2023 Q2 | 914.5 Thousand EUR | -0.0% |
| 2022 Q3 | 2.18 Million EUR | -36.15% |
| 2022 FY | 7.78 Million EUR | 71.35% |
| 2022 Q4 | 2.18 Million EUR | 0.0% |
| 2022 Q1 | 1.71 Million EUR | -19.7% |
| 2022 Q2 | 3.42 Million EUR | 100.0% |
| 2021 Q1 | 1.2 Million EUR | -55.66% |
| 2021 FY | 4.54 Million EUR | -20.31% |
| 2021 Q4 | 2.13 Million EUR | 100.0% |
| 2021 Q3 | 1.06 Million EUR | -55.91% |
| 2021 Q2 | 2.41 Million EUR | 100.0% |
| 2020 FY | 5.7 Million EUR | -29.33% |
| 2020 Q1 | 1.48 Million EUR | -35.36% |
| 2020 Q2 | 2.97 Million EUR | 100.0% |
| 2020 Q3 | 1.36 Million EUR | -54.29% |
| 2020 Q4 | 2.72 Million EUR | 100.0% |
| 2019 Q4 | 2.3 Million EUR | 112.05% |
| 2019 FY | 8.07 Million EUR | 12.55% |
| 2019 Q3 | 1.08 Million EUR | -36.54% |
| 2019 Q2 | 1.71 Million EUR | -35.24% |
| 2019 Q1 | 2.64 Million EUR | 29.09% |
| 2018 Q3 | 2.75 Million EUR | 236.51% |
| 2018 Q2 | 819 Thousand EUR | -47.06% |
| 2018 Q1 | 1.54 Million EUR | -6.53% |
| 2018 FY | 7.17 Million EUR | 27.55% |
| 2018 Q4 | 2.04 Million EUR | -25.65% |
| 2017 Q1 | 4.42 Million EUR | 194.35% |
| 2017 Q3 | 412 Thousand EUR | 147.25% |
| 2017 Q4 | 1.65 Million EUR | 301.7% |
| 2017 Q2 | -872 Thousand EUR | -119.7% |
| 2017 FY | 5.62 Million EUR | 23.11% |
| 2016 Q4 | 1.5 Million EUR | -5.82% |
| 2016 Q1 | 3.77 Million EUR | 122.35% |
| 2016 FY | 4.56 Million EUR | -32.2% |
| 2016 Q3 | 1.59 Million EUR | 392.9% |
| 2016 Q2 | 324 Thousand EUR | -91.41% |
| 2015 FY | 6.73 Million EUR | 81.39% |
| 2015 Q4 | 1.69 Million EUR | 169.21% |
| 2015 Q3 | 630 Thousand EUR | -1.25% |
| 2015 Q2 | 638 Thousand EUR | 148.25% |
| 2015 Q1 | 257 Thousand EUR | -85.14% |
| 2014 Q4 | 1.72 Million EUR | 65.93% |
| 2014 Q3 | 1.04 Million EUR | 52.12% |
| 2014 Q2 | 685 Thousand EUR | -6.42% |
| 2014 Q1 | 732 Thousand EUR | -47.64% |
| 2014 FY | 3.71 Million EUR | 0.87% |
| 2013 Q2 | 802 Thousand EUR | -52.6% |
| 2013 Q1 | 1.69 Million EUR | 972.16% |
| 2013 FY | 3.68 Million EUR | 70.1% |
| 2013 Q3 | 749 Thousand EUR | -6.61% |
| 2013 Q4 | 1.39 Million EUR | 86.65% |
| 2012 Q3 | 558 Thousand EUR | 416.67% |
| 2012 Q4 | -194 Thousand EUR | -134.77% |
| 2012 Q2 | 108 Thousand EUR | 103.41% |
| 2012 FY | 2.16 Million EUR | 152.88% |
| 2012 Q1 | -3.16 Million EUR | -1372.69% |
| 2011 Q3 | -982 Thousand EUR | -416.84% |
| 2011 Q1 | -8 Million EUR | -2723.93% |
| 2011 FY | -4.09 Million EUR | 50.99% |
| 2011 Q2 | -190 Thousand EUR | 97.63% |
| 2011 Q4 | 249 Thousand EUR | 125.36% |
| 2010 Q1 | 126 Thousand EUR | 12.5% |
| 2010 Q2 | -150 Thousand EUR | -219.05% |
| 2010 Q3 | -502 Thousand EUR | -234.67% |
| 2010 FY | -8.34 Million EUR | -2197.74% |
| 2010 Q4 | 305 Thousand EUR | 160.76% |
| 2009 Q4 | 112 Thousand EUR | 314.81% |
| 2009 Q2 | 133 Thousand EUR | 0.0% |
| 2009 FY | 398 Thousand EUR | -81.17% |
| 2009 Q3 | 27 Thousand EUR | -79.7% |
| 2008 Q3 | 525 Thousand EUR | 0.0% |
| 2008 FY | 2.11 Million EUR | 1501.52% |
| 2007 FY | 132 Thousand EUR | -95.5% |
| 2006 FY | 2.93 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| DocCheck AG | 2.27 Million EUR | -116.58% |
| CompuGroup Medical SE & Co. KGaA | 45.91 Million EUR | 89.286% |
| Nexus AG | 24.03 Million EUR | 79.528% |